Unveiling the lymph node drainage route in stage IB1 to IIA2 cervical cancer: insights from a retrospective cohort study

This study aimed to identify the drainage route and the first station of lymph node metastasis (LNM) in patients with stage IB1 to IIA2 cervical cancer. The clinicopathological data of stage IB1 to IIA2 cervical cancer patients who underwent radical surgery between 2018 and 2022 were retrospectively retrieved and assessed. Hematoxylin and eosin-stained cervical cancer specimens, including cervix and lymph node tissues, were collected and reviewed independently by two pathologists blinded to the patients’ clinical information. Of the 429 investigated patients, the mean number of lymph nodes removed per patient was 30, and the number of lymph nodes removed between the left and right pelvis was comparable. Additionally, of the 121 (28.2%) patients with LNM, the number of LNM between the left and right pelvis was comparable, and 64 (52.9%) patients had one area of LNM. The internal iliac lymph node was the primary area of LNM, followed by the obturator and external iliac lymph nodes. These three areas accounted for approximately 80% of all LNM cases. We also observed that in cases with LNM in any of these three areas, the second station of drainage area was fixed in more than 50% of patients. The most common first stations of LNM in stage IB1–IIA2 cervical cancer patients were found to be the internal iliac, obturator and external iliac lymph nodes in sequence, and complete removal of these lymph nodes is crucial for those without satisfactory or even failed sentinel lymph node mapping.

Cervical cancer; Sentinel lymph node; Drainage route; Mapping; Lymph node metastasis

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68: 394–424.

[2] Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2019; 17: 64–84.

[3] Hu H, Fu M, Huang X, Huang J, Gao J. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Translational Cancer Research. 2022; 11: 1713–1721.

[4] Hinkova N, Strateva D, Tanchev L, Tzvetkov C, Gorchev G. Lymphorhoea—complication after lymph node dissection in cervical cancer. Akusherstvo I Ginekologii︠a︡. 2010; 49: 33–37. (In Bulgarian)

[5] Niebling MG, Pleijhuis RG, Bastiaannet E, Brouwers AH, van Dam GM, Hoekstra HJ. A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. European Journal of Surgical Oncology. 2016; 42: 466–473.

[6] Geppert B, Lönnerfors C, Bollino M, Arechvo A, Persson J. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecologic Oncology. 2017; 145: 256–261.

[7] Bollino M, Geppert B, Lönnerfors C, Falconer H, Salehi S, Persson J. Pelvic sentinel lymph node biopsy in endometrial cancer—a simplified algorithm based on histology and lymphatic anatomy. International Journal of Gynecological Cancer. 2020; 30: 339–345.

[8] Marnitz S, Köhler C, Bongardt S, Braig U, Hertel H, Schneider A. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecologic Oncology. 2006; 103: 35–44.

[9] Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. The Lancet Oncology. 2017; 18: 384–392.

[10] Huang S, He F. Cervical cancer invading the uterine corpus and sigmoid colon: a case report. Case Reports in Women’S Health. 2022; 36: e00455.

[11] Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. International Journal of Gynecology & Obstetrics. 2018; 143: 22–36.

[12] Corrigendum to “Revised FIGO staging for carcinoma of the cervix uteri” [Int J Gynecol Obstet 145(2019) 129–135]. International Journal of Gynaecology and Obstetrics. 2019; 147: 279–280.

[13] Li G, Yan X, Shang H, Wang G, Chen L, Han Y. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer. Gynecologic Oncology. 2007; 105: 176–180.

[14] Yan X, Li G, Shang H, Wang G, Han Y, Lin T, et al. Twelve-year experience with laparoscopic radical hysterectomy and pelvic lymphadenectomy in cervical cancer. Gynecologic Oncology. 2011; 120: 362–367.

[15] Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecologic Oncology. 1990; 38: 352–357.

[16] Matsuo K, Klar M, Ciccone MA, Nusbaum DJ, Shimada M, Roman LD, et al. Incorporation of sentinel lymph node biopsy in cervical cancer surgery: recent U.S. trends. European Journal of Surgical Oncology. 2022; 48: 1407–1413.

[17] Wu Y, Li Z, Wu H, Yu J. Sentinel lymph node biopsy in cervical cancer: a meta-analysis. Molecular and Clinical Oncology. 2013; 1: 1025–1030.

[18] Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi L, et al. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature. European Journal of Surgical Oncology. 2015; 41: 1–20.

[19] Kadan Y, Baron A, Brezinov Y, Ben Arie A, Fishman A, Beiner M. Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers. Gynecologic Oncology Reports. 2022; 39: 100917.

[20] Dabi Y, Bendifallah S, Kolanska K, Boudy AS, Querleu D, Akladios C, et al. Anatomical basis of lymph node detection in gynecologic cancers: a review from a surgical perspective. Chinese Clinical Oncology. 2021; 10: 15.

[21] Eiriksson LR, Covens A. Sentinel lymph node mapping in cervical cancer: the future? BJOG. 2012; 119: 129–133.

[22] Aoki Y, Kanao H, Fusegi A, Omi M, Okamoto S, Tanigawa T, et al. Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer. International Journal of Clinical Oncology. 2022; 27: 1499–1506.

[23] Lührs O, Ekdahl L, Geppert B, Lönnerfors C, Persson J. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer. Gynecologic Oncology. 2021; 163: 289–293.